Company intelligence / Profile preview

Biotis Pharmaceutical Indonesia

Bogor, West Java, Indonesia

Ownership: Private
Development stage: Other

Overview

PT Biotis Pharmaceutical Indonesia is a private biopharmaceutical company based in Indonesia, established in 2020 to bolster the nation's vaccine self-sufficiency. The company is the second human vaccine manufacturer in Indonesia and is best known for producing InaVac (formerly known as the Merah Putih vaccine), a COVID-19 vaccine developed in collaboration with Airlangga University. Biotis operates a sophisticated manufacturing facility in Bogor, West Java, which adheres to international Good Manufacturing Practice (GMP) standards. Beyond COVID-19, the company is focused on developing a broader range of vaccine products to address various infectious diseases and enhance regional health security.

Therapeutic areas: Infectious Diseases
Modalities: VaccineInactivated virus
Industry: Biotech

Partnerships

Universitas Airlangga

Beyond the preview

Go deeper on Biotis Pharmaceutical Indonesia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biotis Pharmaceutical Indonesia.

Explore the full profile